Founded in July 2025, Hematology Dept of Shenzhen Bao'an District Songgang People's Hospital has achieved rapid development starting from scratch. The department comprises a Hematological Oncology Clinic and an inpatient ward, with an annual outpatient volume of approximately 3,500 visits.

Scope of Diagnosis and Treatment

1. All types of anemia: Aplastic anemia, autoimmune hemolytic anemia, paroxysmal nocturnal hemoglobinuria, etc.

2. Coagulation and bleeding disorders: Hemophilia, disseminated intravascular coagulation (DIC), hereditary coagulation factor deficiencies, etc.

3. Acute and chronic leukemias: Acute leukemia, chronic myeloid leukemia, chronic lymphocytic leukemia, etc.

4. Plasma cell disorders: Monoclonal gammopathy of undetermined significance (MGUS), POEMS syndrome, smoldering myeloma, multiple myeloma, extramedullary plasmacytoma, light chain amyloidosis, etc.

5. Malignant lymphomas: Hodgkin lymphoma, diffuse large B-cell lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, plasmablastic lymphoma, Waldenström macroglobulinemia/lymphoplasmacytic lymphoma, anaplastic large cell lymphoma, angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, NK/T-cell lymphoma, etc.

6. Chronic myeloproliferative neoplasms

7. Thrombocytopenic disorders: Primary immune thrombocytopenia, thrombotic thrombocytopenic purpura

8. Hematological emergencies: Acute hemolysis, tumor lysis syndrome, hemophagocytic syndrome, febrile neutropenia combined with septic shock, etc.

9. Rare hematological diseases: Castleman disease, lymphomatoid granulomatosis, Langerhans cell histiocytosis/sarcoma, Kimura disease, etc.

10. Autologous hematopoietic stem cell transplantation: For lymphoma, multiple myeloma and leukemia

11. CAR-T cell therapy: For acute lymphoblastic lymphoma, lymphoma and multiple myeloma

Discipline Development Plan

1. Taking chemotherapy as the foundation, CAR-T cell therapy as the innovative driving force, and autologous hematopoietic stem cell transplantation as the consolidating treatment tool, the department aims to build a regional center for cell therapy and autologous bone marrow transplantation in western Shenzhen.

2. Subspecialty Construction: Establish five sub-specialties including anemia disorders, leukemia, bleeding and coagulation disorders, lymphoma & multiple myeloma, as well as autologous bone marrow transplantation and cell therapy.

Compliance Notes

1. Standard hospital name: Shenzhen Bao'an District Songgang People's Hospital (implemented strictly as required)

2. Department name follows Shenzhen medical bilingual sign specification: Hematology Dept

3. All hematological diseases, tumor subtypes and cell therapy technologies adopt internationally recognized standard medical English terminology; universal medical abbreviations such as CAR-T, MGUS, POEMS, DIC are retained directly

4. Formal and concise sentence structure, suitable for hospital department introduction display panels